Opko Health, Inc. share price logo

Opko Health, Inc. Share Price

NASDAQ: OPK

Small Cap

$1.19

-0.02

(-2.07%)

Live

as on

Opko Health, Inc. Stock Performance

as on March 11, 2026 at 6:59 am IST

  • Day's Low

    Day's High

    $1.18
    $1.22
    downward going graph

    0.84%

    Downside

    2.52%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $1.11
    $1.95
    downward going graph

    6.72%

    Downside

    63.87%

    Upside

    downward going graph

Opko Health, Inc. share price movements today

Previous Close
$1.21
Open
$1.20
Volume
1.3M
Day's Low - High
$1.18 - $1.22
52 Week Low - High
$1.11 - $1.95

Opko Health, Inc. Historical Returns

1 Month Return
-0.82 %
3 Month Return
-11.68 %
1 Year Return
-34.24 %
3 Year Return
-2.42 %
5 Year Return
-71.93 %

Opko Health, Inc. Stock Fundamentals & Key Indicators

Check Opko Health, Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$905.9M

EPS (TTM)

-0.34

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

-0.13%

PE Ratio (TTM)

-4.56

Industry PE ratio

-3.0981227436823104

PEG Ratio

93.6471

EBITDA

-127.4M

Revenue (TTM)

606.9M

Profit Margin

-37.19%

Return On Equity TTM

-17.14%

Opko Health, Inc. Stock Valuation

Track how Opko Health, Inc. P/E has moved over time to understand its valuation trends.

Opko Health, Inc. in the last 5 years

  • Overview

  • Trends

Lowest (-134.91x)

December 31, 2021

Today (-4.56x)

March 10, 2026

Industry (-3.10x)

March 10, 2026

Highest (30.16x)

June 30, 2021

LowHigh

Today’s Price to Earnings Ratio: -4.56x

Opko Health, Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Opko Health, Inc. with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
Opko Health, Inc. image
Opko Health, Inc.
BUY$905.9M-71.93%-4.56-37.19%
Idexx Laboratories, Inc. image
Idexx Laboratories, Inc.
BUY$48.6B24.89%46.5124.62%
Thermo Fisher Scientific, Inc. image
Thermo Fisher Scientific, Inc.
BUY$186.5B15.62%28.3315.05%
Iqvia Holdings Inc. image
Iqvia Holdings Inc.
BUY$30.4B-5.9%22.88.34%
Agilent Technologies Inc. image
Agilent Technologies Inc.
BUY$33.0B-2.79%25.7518.26%
See all

Stock Returns calculator for Opko Health, Inc. Stock including INR - Dollar returns

The Opko Health, Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Opko Health, Inc. investment value today

Current value as on today

₹69,866

Returns

₹30,134

(-30.13%)

Returns from Opko Health, Inc. Stock

₹35,326 (-35.33%)

Dollar Returns*

₹5,192 (+5.19%)

Analyst Recommendation on Opko Health, Inc. Stock

Based on 10 analysts

BUY

90.00%

Buy

10.00%

Hold

0.00%

Sell

Based on 10 analysts, 90% of analysts recommend a 'BUY' rating for Opko Health, Inc.. Average target price of $3.4

Opko Health, Inc. Share Price Target

Get share price movements and forecasts by analysts on Opko Health, Inc..

What analysts predicted

65%UPSIDE

Target Price

$3.4

Current Price

$1.19

Analyzed by

10 Analysts

Target

$3.40

Opko Health, Inc. target price $3.4, a slight upside of 65% compared to current price of $1.19. According to 10 analysts rating.

Opko Health, Inc. Stock’s Investor Sentiment and Interest

Search interest for Opko Health, Inc. Stock has decreased by -25% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-25% versus previous 30 day period

Opko Health, Inc. Quarterly Profit & Loss

All numbers in Millions USD

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Total Revenue
178
181
173
182
173
183
149
156
151
148
Gross Profit
47
44
42
51
40
84
42
49
71
88
Operating Income
-64
-69
-71
-61
14
-33
-67
-59
48
-38
EBITDA
-48
-43
-49
21
89
73
-34
-69
75
-20
Interest Expense
3
3
7
8
17
14
15
70
11
4
Depreciation
21
25
25
24
24
24
23
23
22
22
Income Before Tax
-78
-72
-83
-10
48
34
-73
-162
41
-46
Income Tax Expense
6
-6
-1
0
23
20
-5
-14
19
-15
Net Income
-84
-66
-81
-10
24
14
-67
-148
21
-31
Net Profit Margin
-47.30%
-36.55%
-47.12%
-5.66%
14.33%
7.64%
-45.09%
-94.66%
14.26%
-21.08%

Opko Health, Inc. Annual Profit & Loss

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
1,221
966
990
901
1,435
1,774
1,004
863
713
606
Gross Profit
610
345
385
329
541
581
288
318
311
128
Operating Income
-73
-276
-171
-274
57
18
-226
-157
-152
-218
EBITDA
7
-163
-68
-189
155
83
-270
-65
135
-48
Interest Expense
7
6
11
21
21
18
12
13
47
101
Depreciation
-
102
97
93
85
50
108
105
98
91
Income Before Tax
-73
-271
-177
-304
48
-14
-391
-184
-10
-241
Income Tax Expense
-56
18
-38
7
17
15
-63
4
42
-15
Net Income
-48
-305
-153
-314
30
-30
-328
-188
-53
-225
Net Profit Margin
-3.96%
-31.60%
-15.45%
-34.92%
2.13%
-1.70%
-32.70%
-21.87%
-7.46%
-37.20%

Opko Health, Inc. Quarterly Cash Flow

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Net Income
-66
-81
-10
24
14
-67
-148
21
-31
Operating Cash Flow
-38
-35
-26
-77
-44
-34
-83
-34
-25
Investing Cash Flow
-1
-4
-7
247
115
40
-2
194
-2
Financing Cash Flow
-3
20
-2
206
-40
-4
-79
-16
-18
Change in Cash
-42
-20
-35
379
25
4
-164
143
-46

Opko Health, Inc. Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-305
-153
-314
30
-30
-328
-188
-53
-225
Operating Cash Flow
-92
-109
-172
39
38
-95
-28
-183
-178
Investing Cash Flow
-46
-26
-13
-18
35
91
-18
352
230
Financing Cash Flow
61
140
175
-35
-10
22
-11
184
-118
Change in Cash
-77
4
-11
-13
62
18
-57
349
-62

Global Institutional Holdings in Opko Health, Inc.

Funds
Holdings
Marshall Wace Asset Management Ltd
0.42%
Whitefort Capital Management, LP.
0.56%
WASHINGTON GROWTH STRATEGIES LLC
0.18%
Bank of America Corp
0.17%
Bank of New York Mellon Corp
0.17%
See all

Opko Health, Inc. News & Key Events

  • img

    Today's Timeline - 29 October

    Wed, 09:30 PM

    -

    ModeX Therapeutics enters collaboration with Regeneron, receiving $7 million upfront and potential milestone payments exceeding $200 million per molecule.

Insights on Opko Health, Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, OPK stock has moved up by 1.7%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Idexx Laboratories, Inc. has given 34.2% return, outperforming this stock by 36.6%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Idexx Laboratories, Inc. has given 39.9% return, outperforming this stock by 74.1%

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 3 quarters, 156.80M → 148.5M (in $), with an average decrease of 2.7% per quarter

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 2 quarters, 21.63M → -31.3M (in $), with an average decrease of 244.7% per quarter

About Opko Health, Inc.

opko health is a diversified healthcare company that seeks to establish industry leading positions in large, rapidly growing markets. our diagnostics business includes bioreference laboratories, the nation's third largest clinical laboratory with a core genetic testing business and a 400 person sales and marketing team to drive growth and leverage new products, including the 4kscore® prostate cancer test and the claros® 1 in office immunoassay platform. our pharmaceutical business features rayaldee, an fda approved treatment for shpt in stage 3-­4 ckd patients with vitamin d insufficiency (launched in november 2016), varubitm for chemotherapy induced nausea and vomiting (oral formulation launched by partner tesaro and iv formulation pending fda approval), opk88004, a once or twice weekly oxyntomodulin for type 2 diabetes and obesity, in phase 2 clinical trials, among the new class of glp-­1 glucagon receptor dual agonists, and opk88003, a selective androgen receptor modulator for benig
OrganisationOpko Health, Inc.
Headquarters4400 Biscayne Boulevard, Miami, FL, United States, 33137
IndustryHealth Technology
CEODr. Phillip Frost M.D., Ph.D.
E-voting on sharesClick here to vote

Key Management of Opko Health, Inc.

Name

Title

Dr. Phillip Frost M.D., Ph.D.

Chairman & CEO

Dr. Jane H. Hsiao M.B.A., Ph.D.

Vice Chairman & Chief Technical Officer

Dr. Elias Adam Zerhouni M.D.

President & Vice Chairman

Mr. Adam E. Logal

Senior VP, CFO, Chief Accounting Officer & Treasurer

Dr. Gary J. Nabel M.D., Ph.D.

Chief Information Officer & Director

Dr. Akhtar Ashfaq FACP, FASN, M.D.

Senior Vice President of Clinical Research & Development and Medical Affairs - Opko Renal

Dr. John R. Mascola M.D.

Chief Scientific Officer of ModeX

Mr. Steven D. Rubin Esq., J.D.

Executive VP of Administration & Director

Dr. Arie Gutman Ph.D.

President of API

Mr. Giovanni Abbadessa M.D., Ph.D.

Chief Medical Officer of ModeX

FAQs

What is Opko Health, Inc. share price today?

Opko Health, Inc. share price today is $1.19 as on . Opko Health, Inc. share today touched a day high of $1.22 and a low of $1.18.

What is the 52 week high and 52 week low for Opko Health, Inc. share?

Opko Health, Inc. share touched a 52 week high of $1.95 on and a 52 week low of $1.11 on . Opko Health, Inc. stock price today i.e. is trending at $1.19,which is 38.97% down from its 52 week high and 7.21% up from its 52 week low.

What is Opko Health, Inc.'s market capitalisation today?

Opko Health, Inc. market capitalisation is $0.00T as on .

How to invest in Opko Health, Inc. Stock (OPK) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Opko Health, Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Opko Health, Inc. Shares that will get you 1.2605 shares as per Opko Health, Inc. share price of $1.19 per share as on March 11, 2026 at 1:29 am IST.

What is the minimum amount required to buy Opko Health, Inc. Stock (OPK) from India?

Indian investors can start investing in Opko Health, Inc. (OPK) shares with as little as ₹91.833 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹918.33 in Opko Health, Inc. stock (as per the Rupee-Dollar exchange rate as on ). Based on Opko Health, Inc. share’s latest price of $1.19 as on March 11, 2026 at 1:29 am IST, you will get 8.4034 shares of Opko Health, Inc.. Learn more about fractional shares .

What are the returns that Opko Health, Inc. has given to Indian investors in the last 5 years?

Opko Health, Inc. stock has given -71.93% share price returns and 26.32% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?